Aquisição de Antitripsina Alfa-1 1000 Mg Pó Sol Inj Fr IV, de Antitripsina Alfa -1 5000 Mg Pó Sol Inj Fr IV e de Antitripsina Alfa -1 4000 Mg Pó Sol Inj Fr IV
TED · 629190-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded€492,671 · 492,670.6 EUR
WinnerGrifols Portugal - Produtos Farmacêuticos e Hospitalares, Lda.
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Brainlab Sales GmbH | 2 | €2,619,329 | 2026-10-08 |
| Cencora 3PL Portugal, S.A. | 2 | €1,435,097 | 2026-10-28 |
| ROCHE FARMACÊUTICA QUÍMICA, LDA. | 2 | €1,240,039 | 2026-10-29 |
| Cencora 3Pl Portugal, S.A. | 2 | €823,396 | 2026-10-27 |
| Roche Farmacêutica Química, Lda. | 2 | — | 2026-10-08 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Antitripsina Alfa-1 Pó Sol Inj Fr IV – Grifols
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-14 | Aquisição de Antitripsina alfa-1 5000 mg Pó sol inj Fr IV, Antitripsina alfa-1 1000mg Inj IV e Antitripsina alfa-1 4000 mg Pó sol inj Fr IV | Unidade Local de Saúde de Braga, EPE PT | 98% |
| 2026-09-11 | Com base no CPA 2026/0098 – Avalglucosidase Alfa 100 mg Pó | Unidade Local de Saúde de Coimbra, EPE PT | 92% |
| 2026-09-17 | C/ BASE NO CPA 2025_1746 - TREPROSTINILO 10 MG/ML SOL INJ FR 10 ML IV SC | Unidade Local de Saúde de Coimbra, EPE PT | 91% |
| 2026-07-17 | Rurioctocog Alfa Pegol Pó Sol Inj Fr Iv | Unidade Local de Saúde de Coimbra, EPE PT | 91% |
| 2026-09-14 | Com base no cpa 2025_1303 - Glofitamab - justificação clinica | Unidade Local de Saúde de Coimbra, EPE PT | 91% |
| 2026-10-27 | VELMANASE ALFA 10 MG PÓ SOL INJ FR IV | Unidade Local de Saúde de Coimbra, EPE PT | 91% |